Business Context and Reporting Period
This Form 8-K Current Report was filed by Protalix Biotherapeutics, Inc. on November 29, 2007. The filing addresses corporate governance matters related to the Company's 2007 Annual Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder meeting logistics and does not contain financial performance data.
Material Changes
There are no material changes to financial operations or business strategy reported in this document. The primary event is the administrative setting of a record date for the upcoming annual meeting.
Guidance, Outlook, and Management Commentary
- Record Date: The Board of Directors set the close of business on December 24, 2007, as the record date for shareholders entitled to receive notice of and vote at the 2007 Annual Meeting.
- Proposal Deadline: The deadline for submitting shareholder proposals pursuant to Rule 14a-8 and for submitting "timely" proposals under Rule 14a-4(c) has been extended to December 24, 2007.
- Submission Requirements: Proposals must be received by the Company on or prior to December 24, 2007, at its principal executive offices in Carmiel, Israel.
Investor Verification Checklist
- Verify the record date of December 24, 2007, to determine eligibility to vote at the 2007 Annual Meeting.
- Confirm the December 24, 2007, deadline for submitting shareholder proposals to ensure timely consideration.
- Review the attached press release (Exhibit 99.1) for additional details regarding the Annual Meeting agenda.